These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8608324)
1. Inhibition of lipopolysaccharide-induced TNF-alpha production by semisynthetic polymyxin-B conjugated dextran. Coyne CP; Moritz JT; Fenwick BW Biotechnol Ther; 1994-1995; 5(3-4):137-62. PubMed ID: 8608324 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-alpha synthesis by polymyxin B sulfate. Coyne CP; Fenwick BW Am J Vet Res; 1993 Feb; 54(2):305-14. PubMed ID: 8430940 [TBL] [Abstract][Full Text] [Related]
3. Semi-synthesis of polymyxin-B conjugated ovalbumin: evaluation of lipopolysaccharide binding avidity and neutralization of induced tnf-alpha synthesis. Coyne CP; Moritz JT; Langston VC Biotherapy; 1994; 8(1):69-83. PubMed ID: 7547083 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Bucklin SE; Lake P; Lögdberg L; Morrison DC Antimicrob Agents Chemother; 1995 Jul; 39(7):1462-6. PubMed ID: 7492086 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014 [TBL] [Abstract][Full Text] [Related]
6. Polymyxin-B stimulates tumor necrosis factor-alpha production by human peripheral blood mononuclear cells. Jaber BL; Sundaram S; Cendoroglo Neto M; King AJ; Pereira BJ Int J Artif Organs; 1998 May; 21(5):269-73. PubMed ID: 9684908 [TBL] [Abstract][Full Text] [Related]
7. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. Swierzko AS; Kirikae T; Kirikae F; Hirata M; Cedzynski M; Ziolkowski A; Hirai Y; Kusumoto S; Yokochi T; Nakano M J Med Microbiol; 2000 Feb; 49(2):127-138. PubMed ID: 10670563 [TBL] [Abstract][Full Text] [Related]
8. Effects of polymyxin-B on TNF-α production in equine whole blood stimulated with three different bacterial toxins. Bauquier JR; Tennent-Brown BS; Tudor E; Bailey SR J Vet Pharmacol Ther; 2018 Feb; 41(1):e35-e39. PubMed ID: 28804940 [TBL] [Abstract][Full Text] [Related]
9. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. Burd RS; Battafarano RJ; Cody CS; Farber MS; Ratz CA; Dunn DL Ann Surg; 1993 Sep; 218(3):250-9; discussion 259-61. PubMed ID: 8373268 [TBL] [Abstract][Full Text] [Related]
10. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. Pappo I; Bercovier H; Berry EM; Haviv Y; Gallily R; Freund HR JPEN J Parenter Enteral Nutr; 1992; 16(6):529-32. PubMed ID: 1494209 [TBL] [Abstract][Full Text] [Related]
11. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. MacKay RJ; Clark CK; Logdberg L; Lake P Am J Vet Res; 1999 Jan; 60(1):68-75. PubMed ID: 9918150 [TBL] [Abstract][Full Text] [Related]
12. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages. Stokes DC; Shenep JL; Fishman M; Hildner WK; Bysani GK; Rufus K J Infect Dis; 1989 Jul; 160(1):52-7. PubMed ID: 2543712 [TBL] [Abstract][Full Text] [Related]
13. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Iwagaki A; Porro M; Pollack M Infect Immun; 2000 Mar; 68(3):1655-63. PubMed ID: 10678985 [TBL] [Abstract][Full Text] [Related]
14. Polymyxin B-conjugated alpha 2-macroglobulin as an adjunctive therapy to sepsis: Modes of action and impact on lethality. Birkenmeier G; Nicklisch S; Pockelt C; Mossie A; Steger V; Gläser C; Hauschildt S; Usbeck E; Huse K; Sack U; Bauer M; Schäfer A J Pharmacol Exp Ther; 2006 Aug; 318(2):762-71. PubMed ID: 16705081 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. Tsuzuki H; Tani T; Ueyama H; Kodama M J Surg Res; 2001 Sep; 100(1):127-34. PubMed ID: 11516215 [TBL] [Abstract][Full Text] [Related]
16. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530 [TBL] [Abstract][Full Text] [Related]
17. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. Gallay P; Jongeneel CV; Barras C; Burnier M; Baumgartner JD; Glauser MP; Heumann D J Immunol; 1993 Jun; 150(11):5086-93. PubMed ID: 7684419 [TBL] [Abstract][Full Text] [Related]
18. Effects of lipopolysaccharide on macrophages analyzed with anti-lipid A monoclonal antibodies and polymyxin B. Lasfargues A; Tahri-Jouti MA; Pedron T; Girard R; Chaby R Eur J Immunol; 1989 Dec; 19(12):2219-25. PubMed ID: 2481587 [TBL] [Abstract][Full Text] [Related]
19. Effects of pentoxifylline and polymyxin B on the acute-phase-response to Escherichia coli endotoxin in dwarf goats. van Miert AS; van Duin CT; Wensing T J Vet Pharmacol Ther; 1997 Feb; 20(1):61-8. PubMed ID: 9049951 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. Chia JK; Pollack M; Guelde G; Koles NL; Miller M; Evans ME J Infect Dis; 1989 May; 159(5):872-80. PubMed ID: 2651532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]